Growth Strategies Innovation Essays

2960 Words Dec 13th, 2014 12 Pages
Growth Strategies, Innovation, Alliances, and Execution
Oscar Gonzales

Growth Strategies, Innovation, Alliances, and Execution u10a1, DB8004-01, Spring 2012
Introduction
Founded in 1885 in New Brunswick, New Jersey by brothers James and Edward Mead Johnson, Johnson and Johnson began as an antiseptic surgical dressing’s manufacturer. Today, Johnson & Johnson has approximately 117,900 employees throughout the globe, is comprised of three strategic business segments (SBU’s), and has a presence in almost every country in the world (Johnson and Johnson, 2012).
Johnson and Johnson spends nearly $5 billion on pharmaceutical research and development annually. Johnson and Johnson has a long history of acquisition and diversification
…show more content…
The next generation of SBU creates competitive advantages by creating an environment of activity sharing, sourcing, and re-combination. By interconnecting SBUs, an organization can create cross-unit synergies, facilitate outsourcing, and foster growth through strategic alliances at the same functional level (Jonk, 2007).
Johnson and Johnson is comprised of three strategic business segments (SBU’s): the consumer segment includes infant and child care products, dental and skin care, products for women, nutritional, pharmacological, and wellness products. With $14.9 billion in sales in 2011, Johnson and Johnson’s consumer business SBU is the sixth largest consumer health care company in the world (Johnson and Johnson, 2012). Consumer products are marketed and sold to distributors, retail outlets and to the general public and; with $24.4 billion in sales in 2011, Johnson and Johnson is the eighth largest pharmaceuticals business and the sixth largest biotech business in the world. This SBU includes products in drugs used to treat a multitude of illnesses and conditions including psychosis, gynecological, digestive system, immunology, hematology, oncology, neurology, dermatological, hyper coagulation disorders, vaccines, and infectious diseases. These products are distributed directly to retailers and wholesalers in health care; and the medical devices and diagnostics segment which is the largest in the world. This SBU includes a broad

Related Documents